COMING UP-Reuters interview with Glaxo CEO

Reuters will shortly be moving an exclusive interview with
Andrew Witty, chief executive of GlaxoSmithKline (GSK.L: ),
Britain’s biggest drugmaker.

Witty talks about acquisitions and potential cash returns to
shareholders, as well as his ambition to produce cheaper
medicines for treating rare diseases.

COMING UP-Reuters interview with Glaxo CEO